已收盤 05-08 16:00:00 美东时间
-0.820
-6.97%
Hudson Pacific Properties (NYSE:HPP) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.18 by 42.11 percent. This is a 285.71 percent increase over earnings of $0.07 per share
05-07 21:06
极度看涨!近8成资金押注英伟达继续冲顶;多张Call单大涨超600%,AMD登顶历史新高;死而复生?超微电脑绩后狂飙25%,期权爆量看涨占比冲破75%>>
05-07 19:48
今日重点评级关注:Citizens:维持Avalo Therapeutics"跑赢大市"评级,目标价从52美元升至62美元;BTIG:维持Avalo Therapeutics"买入"评级,目标价从40美元升至58美元
05-07 12:37
BTIG analyst Thomas Catherwood reiterates Hudson Pacific Properties (NYSE:HPP) with a Buy and maintains $26 price target.
05-06 19:03
Sunset Studios Operations UnaffectedHudson Pacific Properties, Inc. (NYSE:HPP) today announced its Quixote subsidiaries will commence the phased wind-down of leased sound stage facilities and Atlanta-area operations,
04-28 21:17
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
今日重点评级关注:Canaccord Genuity:维持Generac控股"买入"评级,目标价从275美元升至300美元;Oppenheimer:维持Biogen"跑赢大市"评级,目标价从250美元升至275美元
04-02 16:17
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
04-01 16:34
Morgan Stanley analyst Ronald Kamdem maintains Hudson Pacific Properties (NYSE:HPP) with a Underweight and lowers the price target from $8 to $5.
04-01 00:51
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22